Your browser doesn't support javascript.
loading
U.S. Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer.
Singh, Harpreet; Walker, Amanda J; Amiri-Kordestani, Laleh; Cheng, Joyce; Tang, Shenghui; Balcazar, Pamela; Barnett-Ringgold, Kimberly; Palmby, Todd R; Cao, Xianhua; Zheng, Nan; Liu, Qi; Yu, Jingyu; Pierce, William F; Daniels, Selena R; Sridhara, Rajeshwari; Ibrahim, Amna; Kluetz, Paul G; Blumenthal, Gideon M; Beaver, Julia A; Pazdur, Richard.
Afiliação
  • Singh H; U.S. Food and Drug Administration, White Oak, Maryland. Harpreet.Singh@fda.hhs.gov.
  • Walker AJ; U.S. Food and Drug Administration, White Oak, Maryland.
  • Amiri-Kordestani L; U.S. Food and Drug Administration, White Oak, Maryland.
  • Cheng J; U.S. Food and Drug Administration, White Oak, Maryland.
  • Tang S; U.S. Food and Drug Administration, White Oak, Maryland.
  • Balcazar P; U.S. Food and Drug Administration, White Oak, Maryland.
  • Barnett-Ringgold K; U.S. Food and Drug Administration, White Oak, Maryland.
  • Palmby TR; U.S. Food and Drug Administration, White Oak, Maryland.
  • Cao X; U.S. Food and Drug Administration, White Oak, Maryland.
  • Zheng N; U.S. Food and Drug Administration, White Oak, Maryland.
  • Liu Q; U.S. Food and Drug Administration, White Oak, Maryland.
  • Yu J; U.S. Food and Drug Administration, White Oak, Maryland.
  • Pierce WF; U.S. Food and Drug Administration, White Oak, Maryland.
  • Daniels SR; U.S. Food and Drug Administration, White Oak, Maryland.
  • Sridhara R; U.S. Food and Drug Administration, White Oak, Maryland.
  • Ibrahim A; U.S. Food and Drug Administration, White Oak, Maryland.
  • Kluetz PG; U.S. Food and Drug Administration, White Oak, Maryland.
  • Blumenthal GM; U.S. Food and Drug Administration, White Oak, Maryland.
  • Beaver JA; U.S. Food and Drug Administration, White Oak, Maryland.
  • Pazdur R; U.S. Food and Drug Administration, White Oak, Maryland.
Clin Cancer Res ; 24(15): 3486-3491, 2018 08 01.
Article em En | MEDLINE | ID: mdl-29523624
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article